Swedencare acquires operations from US-based company
September 25, 2020
Swedencare has also announced its acquisition of the operations of the American pet health company, Animal Pharmaceuticals Inc. Through the acquisition Swedencare will receive a product portfolio of supplements and topical products in the premium segment for dogs and cats. The acquired business had sales of USD 6.2m for the period July 2019 – June 2020 and EBITDA of USD 2.1m. The purchase price is USD 15m with a possible additional purchase price of USD 10m on a cash- and debt-free basis, implying a max. EV / EBITDA multiple of 11.9x.
ⓘ This story was originally featured in our daily M&A Insights newsletter.